TCL Archive Mendelsohn Defends ImClone’s Actions And His Role In Development of C225 October 18, 2002
TCL Archive NCI Seeks to Maintain Grant Success Rate As Budget Deadlock Deepens on Capitol Hill April 25, 2013
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive NIH Grants: NIH Can’t Award Funds To Schools That Prevent Military Recruiting September 12, 1997
TCL Archive Working Group Proposes “Equitable” Schema For Determining Cancer Center Core Grants July 3, 2013
